FindTrial
Sign In

Intralesional Injection of Ethanolamine Oleate Alone or Mixed with Bupivacaine in Oral Venous Malformation (Randomized Controlled Trial)

Intralesional Injection of Ethanolamine Oleate Alone or Mixed with Bupivacaine in Oral Venous Malformation (Randomized Controlled Trial)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202209738652499
Enrollment
16
Registered
2022-09-16
Start date
2021-11-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral Health

Interventions

Ethanolamine Oleate and Lidocaine injection
Ethanolamine Oleate only injection

Sponsors

Oral and Maxillofacial Surgery Department Faculty of Dentistry Alexandria University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients suffering from oral vascular malformations with a size of 2- 4 cm

Exclusion criteria

Exclusion criteria: High flow vascular malformations. Patient’s medication interfering with coagulation and wound healing(e.g., steroids, bisphosphonates, anticoagulants) or specific states preventing the use of EAO (e.g., pregnancy, lactation).

Design outcomes

Primary

MeasureTime frame
Pain score visual analogue scale—

Secondary

MeasureTime frame
Size of oral venous malformation—

Countries

Egypt

Contacts

Public ContactElsayedamr Basma

Patient Information Manager

elsayedamr@yahoo.com00201223106023

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026